Reviews - 4h6j mentioned but not cited (2)
- Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection. Cheng L, Yu H, Yan N, Lai K, Xiang M. Front Cell Neurosci 11 20 (2017)
- bHLH-PAS Proteins: Their Structure and Intrinsic Disorder. Kolonko M, Greb-Markiewicz B. Int J Mol Sci 20 E3653 (2019)
Articles - 4h6j mentioned but not cited (36)
- NPAS1-ARNT and NPAS3-ARNT crystal structures implicate the bHLH-PAS family as multi-ligand binding transcription factors. Wu D, Su X, Potluri N, Kim Y, Rastinejad F. Elife 5 e18790 (2016)
- Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction. Cardoso R, Love R, Nilsson CL, Bergqvist S, Nowlin D, Yan J, Liu KK, Zhu J, Chen P, Deng YL, Dyson HJ, Greig MJ, Brooun A. Protein Sci 21 1885-1896 (2012)
- Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1/HIF-1α interaction in lung cancer. Ullah A, Leong SW, Wang J, Wu Q, Ghauri MA, Sarwar A, Su Q, Zhang Y. Cell Death Dis 12 490 (2021)
- Hypoxia inducible factor (HIF) as a model for studying inhibition of protein-protein interactions. Burslem GM, Kyle HF, Nelson A, Edwards TA, Wilson AJ. Chem Sci 8 4188-4202 (2017)
- A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis. Yan Y, He M, Zhao L, Wu H, Zhao Y, Han L, Wei B, Ye D, Lv X, Wang Y, Yao W, Zhao H, Chen B, Jin Z, Wen J, Zhu Y, Yu T, Jin F, Wei M. Cell Death Differ 29 1769-1789 (2022)
- Identification of Novel Melanin Synthesis Inhibitors From Crataegus pycnoloba Using an in Vivo Zebrafish Phenotypic Assay. Agalou A, Thrapsianiotis M, Angelis A, Papakyriakou A, Skaltsounis AL, Aligiannis N, Beis D. Front Pharmacol 9 265 (2018)
- The Aryl Hydrocarbon Receptor (AhR) Mediates the Counter-Regulatory Effects of Pelargonidins in Models of Inflammation and Metabolic Dysfunctions. Biagioli M, Carino A, Fiorucci C, Annunziato G, Marchianò S, Bordoni M, Roselli R, Giorgio CD, Castiglione F, Ricci P, Bruno A, Faccini A, Distrutti E, Baldoni M, Costantino G, Fiorucci S. Nutrients 11 E1820 (2019)
- Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer. Li H, Hung A, Yang AWH. Sci Rep 11 6656 (2021)
- Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy. Zhang M, Yang J, Zhao X, Zhao Y, Zhu S. Sci Rep 11 7382 (2021)
- Unsaturated fatty acids as high-affinity ligands of the C-terminal Per-ARNT-Sim domain from the Hypoxia-inducible factor 3α. Fala AM, Oliveira JF, Adamoski D, Aricetti JA, Dias MM, Dias MVB, Sforça ML, Lopes-de-Oliveira PS, Rocco SA, Caldana C, Dias SMG, Ambrosio ALB. Sci Rep 5 12698 (2015)
- The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis. Lozza L, Moura-Alves P, Domaszewska T, Lage Crespo C, Streata I, Kreuchwig A, Puyskens A, Bechtle M, Klemm M, Zedler U, Silviu Ungureanu B, Guhlich-Bornhof U, Koehler AB, Stäber M, Mollenkopf HJ, Hurwitz R, Furkert J, Krause G, Weiner J, Jacinto A, Mihai I, Leite-de-Moraes M, Siebenhaar F, Maurer M, Kaufmann SHE. Sci Rep 9 10878 (2019)
- VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo. Kang G, Hu M, Ren H, Wang J, Cheng X, Li R, Yuan B, Balan Y, Bai Z, Huang H. Cancer Biol Med j.issn.2095-3941.2020.0568 (2021)
- Evaluation of pro-apoptotic potential of taxifolin against liver cancer. Butt SS, Khan K, Badshah Y, Rafiq M, Shabbir M. PeerJ 9 e11276 (2021)
- Bioinformatic Prediction of Signaling Pathways for Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) and Its Role in Cholangiocarcinoma Cells. Tummanatsakun D, Proungvitaya T, Roytrakul S, Proungvitaya S. Molecules 26 2587 (2021)
- HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina. Amato R, Pisani F, Laudadio E, Cammalleri M, Lucchesi M, Marracci S, Filippi L, Galeazzi R, Svelto M, Dal Monte M, Bagnoli P. Cells 11 1271 (2022)
- Molecular adaptation to high pressure in cytochrome P450 1A and aryl hydrocarbon receptor systems of the deep-sea fish Coryphaenoides armatus. Lemaire B, Karchner SI, Goldstone JV, Lamb DC, Drazen JC, Rees JF, Hahn ME, Stegeman JJ. Biochim Biophys Acta Proteins Proteom 1866 155-165 (2018)
- Salidroside orchestrates metabolic reprogramming by regulating the Hif-1α signalling pathway in acute mountain sickness. Yan X, Liu J, Zhu M, Liu L, Chen Y, Zhang Y, Feng M, Jia Z, Xiao H. Pharm Biol 59 1540-1550 (2021)
- Deciphering the Efficacy and Mechanism of Astragalus membranaceus on High Altitude Polycythemia by Integrating Network Pharmacology and In Vivo Experiments. Liu X, Zhang H, Yan J, Li X, Li J, Hu J, Shang X, Yang H. Nutrients 14 4968 (2022)
- Spatial transcriptomics analysis of zone-dependent hepatic ischemia-reperfusion injury murine model. Xin J, Yang T, Wu X, Wu Y, Liu Y, Liu X, Jiang M, Gao W. Commun Biol 6 194 (2023)
- Structural Models for the Dynamic Effects of Loss-of-Function Variants in the Human SIM1 Protein Transcriptional Activation Domain. Coban MA, Blackburn PR, Whitelaw ML, Haelst MMV, Atwal PS, Caulfield TR. Biomolecules 10 E1314 (2020)
- A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology. Yin X, Li J, Hao Z, Ding R, Qiao Y. Front Cell Infect Microbiol 12 964469 (2022)
- Druggability assessment of mammalian Per-Arnt-Sim [PAS] domains using computational approaches. de Souza JV, Reznikov S, Zhu R, Bronowska AK. Medchemcomm 10 1126-1137 (2019)
- A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment. Li S, Sun Y, Sun Y. Front Pharmacol 13 768862 (2022)
- Aryl Hydrocarbon Receptor-Dependent and -Independent Pathways Mediate Curcumin Anti-Aging Effects. Brinkmann V, Romeo M, Larigot L, Hemmers A, Tschage L, Kleinjohann J, Schiavi A, Steinwachs S, Esser C, Menzel R, Giani Tagliabue S, Bonati L, Cox F, Ale-Agha N, Jakobs P, Altschmied J, Haendeler J, Coumoul X, Ventura N. Antioxidants (Basel) 11 613 (2022)
- Development of Hif1a Pharmacogenomic Mutation Models to Study Individual Variations in Drug Action for Tumor Hypoxia: An in Silico Approach. Balasubramaniam V, Namboori PKK. J Pharm Bioallied Sci 13 387-393 (2021)
- Mechanism of salidroside in the treatment of endometrial cancer based on network pharmacology and molecular docking. Yang P, Chai Y, Wei M, Ge Y, Xu F. Sci Rep 13 14114 (2023)
- Molecular Docking of Natural Compounds for Potential Inhibition of AhR. Giordano D, Facchiano A, Moccia S, Meola AMI, Russo GL, Spagnuolo C. Foods 12 1953 (2023)
- Pseudoginsengenin DQ exerts antitumour activity against hypopharyngeal cancer cells by targeting the HIF-1α-GLUT1 pathway. Wang S, Cai Y, Feng Q, Gao J, Teng B. Cancer Cell Int 21 382 (2021)
- Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma. Chen C, Liang T, Wu Q, Zhou Z, Zhang M, Feng D, Tao J, Si T, Cai M. Comput Math Methods Med 2022 2940654 (2022)
- The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy. Xia LJ, Zhang LM, Yang K, Chen T, Ye XW, Yan ZJ. Evid Based Complement Alternat Med 2022 9152201 (2022)
- A novel NET-related gene signature for predicting DLBCL prognosis. Shi H, Pan Y, Xiang G, Wang M, Huang Y, He L, Wang J, Fang Q, Li L, Liu Z. J Transl Med 21 630 (2023)
- Erratum: Further Correction: Hypoxia inducible factor (HIF) as a model for studying inhibition of protein-protein interactions. Burslem GM, Kyle HF, Nelson A, Edwards TA, Wilson AJ. Chem Sci 9 2008-2009 (2018)
- Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (Lév.) Hutch Against IgA Nephropathy. Zhao J, Liu H, Xia M, Chen Q, Wan L, Leng B, Tang C, Chen G, Liu Y, Zhang L, Liu H. Drug Des Devel Ther 17 887-900 (2023)
- Preliminary verification of the anti-hypoxia mechanism of Gentiana straminea maxim based on UPLC-triple TOF MS/MS and network pharmacology. Kong XM, Song D, Li J, Jiang Y, Zhang XY, Wu XJ, Ge MJ, Xu JJ, Gao XM, Zhao Q. BMC Complement Med Ther 22 310 (2022)
- Proliferative Effect of Aqueous Extract of Sea Cucumber (Holothuria parva) Body Wall on Human Umbilical Cord Mesenchymal Stromal/Stem Cells. Rasekh P, Kameli A, Khoradmehr A, Baghban N, Mohebbi G, Barmak A, Nabipour I, Azari H, Heidari Y, Daneshi A, Bargahi A, Khodabandeh Z, Zare S, Afshar A, Shirazi R, Almasi-Turk S, Tamadon A. Mar Drugs 21 267 (2023)
- Sequence Analysis and Phylogenetic Studies of Hypoxia-Inducible Factor-1α. Poyya J, Joshi CG, Kumar DJ, Nagendra HG. Cancer Inform 16 1176935117712242 (2017)
Reviews citing this publication (6)
- Advances in covalent drug discovery. Boike L, Henning NJ, Nomura DK. Nat Rev Drug Discov 21 881-898 (2022)
- Structural characterization of mammalian bHLH-PAS transcription factors. Wu D, Rastinejad F. Curr Opin Struct Biol 43 1-9 (2017)
- Targeting Protein-Protein Interactions in the HIF System. Wilkins SE, Abboud MI, Hancock RL, Schofield CJ. ChemMedChem 11 773-786 (2016)
- Fragment-based covalent ligand discovery. Lu W, Kostic M, Zhang T, Che J, Patricelli MP, Jones LH, Chouchani ET, Gray NS. RSC Chem Biol 2 354-367 (2021)
- The design and development of covalent protein-protein interaction inhibitors for cancer treatment. Cheng SS, Yang GJ, Wang W, Leung CH, Ma DL. J Hematol Oncol 13 26 (2020)
- Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. Johnstone S, Albert JS. Bioorg Med Chem Lett 27 2239-2258 (2017)
Articles citing this publication (21)
- Proteome-wide covalent ligand discovery in native biological systems. Backus KM, Correia BE, Lum KM, Forli S, Horning BD, González-Páez GE, Chatterjee S, Lanning BR, Teijaro JR, Olson AJ, Wolan DW, Cravatt BF. Nature 534 570-574 (2016)
- Structural integration in hypoxia-inducible factors. Wu D, Potluri N, Lu J, Kim Y, Rastinejad F. Nature 524 303-308 (2015)
- Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer. Bar-Peled L, Kemper EK, Suciu RM, Vinogradova EV, Backus KM, Horning BD, Paul TA, Ichu TA, Svensson RU, Olucha J, Chang MW, Kok BP, Zhu Z, Ihle NT, Dix MM, Jiang P, Hayward MM, Saez E, Shaw RJ, Cravatt BF. Cell 171 696-709.e23 (2017)
- Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening. Resnick E, Bradley A, Gan J, Douangamath A, Krojer T, Sethi R, Geurink PP, Aimon A, Amitai G, Bellini D, Bennett J, Fairhead M, Fedorov O, Gabizon R, Gan J, Guo J, Plotnikov A, Reznik N, Ruda GF, Díaz-Sáez L, Straub VM, Straub VM, Szommer T, Velupillai S, Zaidman D, Zhang Y, Coker AR, Dowson CG, Barr HM, Wang C, Huber KVM, Brennan PE, Ovaa H, von Delft F, London N. J Am Chem Soc 141 8951-8968 (2019)
- A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. Kathman SG, Xu Z, Statsyuk AV. J Med Chem 57 4969-4974 (2014)
- On the acquisition and analysis of microscale thermophoresis data. Scheuermann TH, Padrick SB, Gardner KH, Brautigam CA. Anal Biochem 496 79-93 (2016)
- Bidirectional modulation of HIF-2 activity through chemical ligands. Wu D, Su X, Lu J, Li S, Hood BL, Vasile S, Potluri N, Diao X, Kim Y, Khorasanizadeh S, Rastinejad F. Nat Chem Biol 15 367-376 (2019)
- A network model for angiogenesis in ovarian cancer. Glass K, Quackenbush J, Spentzos D, Haibe-Kains B, Yuan GC. BMC Bioinformatics 16 115 (2015)
- Covalent Tethering of Fragments For Covalent Probe Discovery. Kathman SG, Statsyuk AV. Medchemcomm 7 576-585 (2016)
- New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas. Toledo RA. Endocr Relat Cancer 24 C9-C19 (2017)
- Modulation of HIF-2α PAS-B domain contributes to physiological responses. Feng Z, Zou X, Chen Y, Wang H, Duan Y, Bruick RK. Proc Natl Acad Sci U S A 115 13240-13245 (2018)
- Modulation of Amyloidogenic Protein Self-Assembly Using Tethered Small Molecules. Cawood EE, Guthertz N, Ebo JS, Karamanos TK, Radford SE, Wilson AJ. J Am Chem Soc 142 20845-20854 (2020)
- A cell-penetrating peptide suppresses the hypoxia inducible factor-1 function by binding to the helix-loop-helix domain of the aryl hydrocarbon receptor nuclear translocator. Wang Y, Thompson JD, Chan WK. Chem Biol Interact 203 401-411 (2013)
- Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif. Kino R, Araya T, Arai T, Sohma Y, Kanai M. Bioorg Med Chem Lett 25 2972-2975 (2015)
- The expression of hypoxia-inducible factor-1α gene is not affected by low-oxygen conditions in yellow perch (Perca flavescens) juveniles. Kwasek K, Rimoldi S, Cattaneo AG, Parker T, Dabrowski K, Terova G. Fish Physiol Biochem 43 849-862 (2017)
- Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor. Dai S, Qu L, Li J, Zhang Y, Jiang L, Wei H, Guo M, Chen X, Chen Y. Nat Commun 13 6234 (2022)
- Structures of NPAS4-ARNT and NPAS4-ARNT2 heterodimers reveal new dimerization modalities in the bHLH-PAS transcription factor family. Sun X, Jing L, Li F, Zhang M, Diao X, Zhuang J, Rastinejad F, Wu D. Proc Natl Acad Sci U S A 119 e2208804119 (2022)
- The action of HIF-3α variants on HIF-2α-HIF-1β heterodimer formation is directly probed in live cells. Kim SH, Hwang D, Park H, Yang EG, Chung HS, Kim SY. Exp Cell Res 336 329-337 (2015)
- Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation. Bum-Erdene K, Ghozayel MK, Xu D, Meroueh SO. ChemMedChem 17 e202100750 (2022)
- Fragile protein folds: Sequence and environmental factors affecting the equilibrium of two interconverting, stably folded protein conformations. Xu X, Dikiy I, Evans MR, Marcelino LP, Gardner KH. Magn Reson (Gott) 2 63-76 (2021)
- Vinyl sulfonamide synthesis for irreversible tethering via a novel α-selenoether protection strategy. Craven GB, Affron DP, Raymond PN, Mann DJ, Armstrong A. Medchemcomm 10 158-163 (2019)